Delivery Order SPE2DB22D2108-SPE2DB23FU4JD
Award Date 8/21/23
Potential Completion Date 8/22/23
Potential Value $754
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $560 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone therapy medication. Performance will take place in Conshohocken, Pennsylvania under the terms of the order placed from August 21-22, 2023. As a major provider of medical supplies and pharmaceuticals, Amerisourcebergen will fulfill this small quantity order of a specialty drug to support the DLA's procurement programs...
- The Defense Logistics Agency awarded a $750 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100mg/0.5ml doses of XYOSTED, an auto-injectable testosterone therapy medication. Performance will take place in Conshohocken, Pennsylvania under the terms of the order placed on July 25, 2023 for delivery by July 26, 2023. As a major provider of medical supplies and pharmaceuticals, Amerisourcebergen will fulfill this requirement for testosterone treatments to support the...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $4,000 to Amerisourcebergen Drug Corporation for the supply of 100mg/0.5ml doses of XYOSTED, an auto-injectable testosterone therapy medication. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of four days from August 4th through August 7th, 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen...
- The Defense Logistics Agency awarded a $798 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone therapy medication. Performance will occur at Amerisourcebergen's Conshohocken, Pennsylvania facility from July 7-10, 2023. The prime contractor, a pharmaceutical wholesaler and distributor, will fulfill this order under an existing DLA-managed contract vehicle to support the agency's medical supply needs. No...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $940 to Amerisourcebergen Drug Corporation for 100mg/0.5ml doses of XYOSTED, an auto-injectable testosterone therapy medication. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a two day period concluding on August 29, 2023. The delivery order was issued under Amerisourcebergen Corporation's corporate office division contract vehicle and...
- The Defense Logistics Agency Troop Support Medical awarded a $554,350 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone replacement drug. Performance will take place in Conshohocken, Pennsylvania under the terms of the contract running from June 26-27, 2023. As a prime contractor supporting DLA's medical supply needs, Amerisourcebergen will deliver this testosterone therapy medication to aid the agency's...
- The Defense Logistics Agency awarded a $683.68 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone replacement drug. As the prime contractor, Amerisourcebergen will deliver the doses from its Conshohocken, Pennsylvania facility to the DLA by June 23, 2023 in support of the agency's medical supply programs. No subcontractors or set aside designations were indicated. The delivery order was issued against an...
- The Defense Logistics Agency awarded a $594.06 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100mg/0.5ml doses of XYOSTED, an auto-injectable testosterone medication. The single order is for delivery to a location in Conshohocken, Pennsylvania by June 27, 2023 to support DLA programs. Amerisourcebergen will perform as the prime contractor, drawing upon its extensive pharmaceutical distribution capabilities to fulfill agency needs on schedule from its...
- The Defense Logistics Agency awarded a $251,420 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 milligram per 0.5 milliliter doses of XYOSTED, an auto-injectable testosterone therapy medication. Performance will take place in Conshohocken, Pennsylvania under the terms of the contract running from August 18-21, 2023. While details of the original solicitation are not provided, this type of order is generally part of DLA's procurement of pharmaceuticals and medical...
- The Defense Logistics Agency awarded a $502,860 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 75 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone therapy. The single order is for product delivery to a location in Conshohocken, Pennsylvania by July 19, 2023 to support the DLA's medical supply needs. Amerisourcebergen will perform as the prime contractor, drawing upon its extensive pharmaceutical distribution capabilities. The award is made...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB23FU4JDDelivery Order
The Defense Logistics Agency awarded a $754 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone therapy medication. Performance will take place in Conshohocken, Pennsylvania under the terms of the contract scheduled from August 21-22, 2023. As a major provider of medical supplies and pharmaceuticals, Amerisourcebergen will fulfill this order to support the DLA's procurement of prescription drugs for military treatment facilities and beneficiaries. No subcontractors or set-aside designations were identified.
Generated 12/24/23, 6:28 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $754 | 8/21/23 |